source
- Curium lists Bexlutry at $63,524 per infusion, roughly 5% cheaper than Novartis' LutatheraCurium announced the list price for its radioligand Bexlutry, a generic version of Novartis' Lutathera. The price is set at $63,524 per infusion, which represents about a five percent discount com…
- Life Biosciences injects experimental cellular reprogramming drug into three glaucoma patients, reports no serious adverse eventsLife Biosciences provided an update on its early‑stage glaucoma study involving its experimental cellular reprogramming therapy. The company said three patients have each received a single intravi…